Fragment and Conquer: From Structure to Complexes to Function  by Guichou, Jean-François & Labesse, Gilles
Structure
PreviewsACKNOWLEDGMENTS
Research in the authors’ laboratory is supported by
grants from NIH (CA141722 and AI064346). Z.T.
was supported by the Ruth L. Kirschstein National
Research Service Award NIH/NCI T32 CA009523.REFERENCES
de Leon-Boenig, G., Bowman, K.K., Feng, J.A.,
Crawford, T., Everett, C., Franke, Y., Oh, A., Stan-ley, M., Staben, S.T., Starovasnik, M.A., et al.
(2012). Structure 20, this issue, 1704–1714.
Lin, X., Mu, Y., Cunningham, E.T., Jr., Marcu, K.B.,
Geleziunas, R., and Greene, W.C. (1998). Mol. Cell.
Biol. 18, 5899–5907.
Liu, J., Sudom, A., Min, X., Cao, Z., Gao, X., Ayres,
M., Lee, F., Cao, P., Johnstone, S., Plotnikova, O.,
et al. (2012). J. Biol. Chem. 287, 27326–27334.
Nolen, B., Taylor, S., and Ghosh, G. (2004). Mol.
Cell 15, 661–675.Structure 20, October 10, 2012 ªRazani, B., Reichardt, A.D., and Cheng, G. (2011).
Immunol. Rev. 244, 44–54.
Rosebeck, S., Madden, L., Jin, X., Gu, S., Apel,
I.J., Appert, A., Hamoudi, R.A., Noels, H., Sa-
gaert, X., Van Loo, P., et al. (2011). Science 331,
468–472.
Sessa, F., Mapelli, M., Ciferri, C., Tarricone, C.,
Areces, L.B., Schneider, T.R., Stukenberg, P.T.,
and Musacchio, A. (2005). Mol. Cell 18, 379–391.
Staudt, L.M. (2010). Cold Spring Harb. Perspect.
Biol. 2, a000109.Fragment and Conquer: From Structure
to Complexes to FunctionJean-Franc¸ois Guichou1,2,3 and Gilles Labesse1,2,3,*
1Atelier de Bio- et Chimie Informatique Structurale, CNRS, UMR5048, Centre de Biochimie Structurale, F-34090 Montpellier, France
2Universite´s Montpellier 1 et 2, 29 rue de Navacelles, 34090 Montpellier, France
3INSERM, U1054, F-34090 Montpellier, France
*Correspondence: labesse@cbs.cnrs.fr
http://dx.doi.org/10.1016/j.str.2012.09.008
In this issue of Structure, Shumilin and colleagues show the power of metabolite screening bymeans of X-ray
crystallography to link an orphan protein domain with an orphan biochemical function. This result paves the
way for large-scale functional annotation and sets new objectives for structural genomics.Whole-genome sequences constitute a
major breakthrough toward the complete
and fine description of most organisms.
Functional annotation of genes and the
function of proteins they encode was ex-
pected to be efficiently guided by genome
comparison and systematic scrutiny by
identifying sequence similarities, gene
neighbors (using the Rosetta stone ap-
proach), and similar strategies developed
over the last decade. Sequence com-
parisons have led to the classification of
protein sequences into families, such as
in the Pfam database (Punta et al.,
2012). It highlighted the existence of
thousands of domains of unknown func-
tion (DUFs; Bateman et al., 2010). In
parallel, structural genomics initiatives
focused on creating a library of all existing
protein folds. Indeed, protein structures
can help to reveal remote similarities and
accordingly extend the repertoire of anno-
tated genes. However, progress toward
achieving this goal has been slow, and
roughly two thousand of the newly solved
structures have no known function.At the same time, traditional biochem-
ical characterization has been partially
neglected over the last two decades,
and we witnessed a shift in education
and research trends toward the more
attractive genetic, cellular and large-scale
omics approaches. In this context, the
recent disclosure of the rising knowl-
edge gap between biochemical function
and sequence information can be seen
as a therapeutic shock (Lespinet and
Labedan, 2005). Limitations appear at
both ends of the annotation problem: not
only many genes are still awaiting func-
tional annotation, but a vast repertoire of
biochemical functions have yet to be
linked to a known gene. About a third
of known enzymatic activities (EC
numbers; http://www.chem.qmul.ac.uk/
iubmb/enzyme/) defined by the Nomen-
clature Committee of the International
Union of Biochemistry and Molecular
Biology are not associated with any
macromolecule in major public data-
bases. The estimated 1,525 orphan activ-
ities (EC numbers without associatedsequences) are found in all classes
of enzymes and in all kingdoms of life
(Chen and Vitkup, 2007). Quite surpris-
ingly, some of these unannotated genes
or orphan activities are found conserved
across thousands of living organisms.
In this issue of Structure, Shumilin et al.
(2012) selected three proteins whose
crystal structures were solved by a struc-
tural genomics consortium but whose
function remained to be characterized.
They cleverly chose a set of proteins that
well illustrated the current challenge for
function annotation. Two proteins, YxkO
from Bacillus subtilis and AI-BP from
mouse, each harbor a DUF (named ac-
cording to their Pfam codes: PF01256
and Yjef_N, respectively). Both protein
families contain thousands of members in
a wide range of organisms (from bacteria,
archea to eukaryotes, including human).
Sequence similarities connected YxkO to
the ATP-dependent ribokinase-like super-
family. This was confirmed by the X-ray
structure of the apo-enzyme, but the
nature of the second substrate remained2012 Elsevier Ltd All rights reserved 1617
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Figure 1. In Cristallo Metabolite Screening
The crystals of an orphan macromolecule (here the protein TM0922) can be soaked with metabolite cock-
tails to highlight potential binders. This can be further refined and subsequent combinations can even
reveal a biochemical catalysis and thus the biological function of the macromolecule.
Structure
Previewsunknown (Zhanget al., 2002). Interestingly,
the crystal structure revealed that the
YjeF-N domain is a novel version of the
Rossmann fold, but its precise function re-
mained unsolved (Jha et al., 2008). The
third protein, TM0922 from Thermotoga
maritima, corresponds to a fusion of the
two above domains: PF01256 and Yjef_N.
This fusion and others involving either
Yjef_N or PF01256 domains suggested
that the Rosetta stone approach could be
fruitful. In fact, a possible connection
to poly-(ADP-ribosyl)-polymerase (PARP)
activitywasproposeddespite the absence
of sequenceorstructuresimilarities shared
by Yjef_N and already known PARP en-
zymes. Nevertheless, the unbound struc-
tures of these enzymes suggested that
nucleotides were the first type of metabo-
lites on which to focus.
While structure-based fragment
screening was successfully applied to
drug design more than a decade ago (re-
viewed in Hajduk and Greer, 2007), it was
never envisioned for functional annota-
tion. Shumilin et al. (2012) described the
design of a set of metabolite cocktails
mostly composed of various nucleotides
and their natural fragments (nucleosides,
nucleobase, etc.) and its use to soak the
crystals of the three proteins described
above. Binding of metabolite(s) was de-
tected in a few cases, whereas in most
cases, either no binding or crystal deterio-1618 Structure 20, October 10, 2012 ª2012 Eration was observed. However, the pro-
ductive binding events and the resulting
structures provided the authors with
sufficient information to carry on further
refinement. This mainly consisted in
cocktail deconvolution to identify the
true ligands. It first confirmed the ATP
binding site in the ribokinase-like domain
PF01256. In parallel, it also defined the
second substrate as an NAD/NADP deriv-
ative. Similarly, the possible PARP activity
of YjeF_N was reinforced first by the
observed binding of NAD (or related
compounds) and second by the binding
of thymine (or its derivatives), which are
the biologically relevant substrates and
competitive inhibitors of PARP activity,
respectively. Here, the detailed struc-
tures of the complexes highlight the
strength of the screening by X-ray crystal-
lography compared to virtual ligand
screening, as ligand binding induced
local but unanticipated conformational
rearrangements.
Follow-up soaking to form ternary
complexes led to the final identification
of the biological function of PF01256.
Because enzymes are often active in the
crystallization conditions, the actual or
biologically relevant products could be
built in situ by soaking with ATP and
NAD(P) to form ADP and NAD(P)HX.
The latter is a hydrated derivative that
forms spontaneously and was knownlsevier Ltd All rights reservedto be converted back to the useful
co-factor NAD(P) in cells. The ATP-
dependent salvaging dehydratase activity
(EC.4.2.1.93) had no associated gene
until now. So, the authors succeed in
performing an elegant de-orphanization
while also providing an in-depth struc-
tural characterization of this enzyme
(Figure 1).
Soaking large substrates represent
a potential limitation of this approach
(due to crystal compactness), and this
prevented the search for the biological
substrate(s) of YjeF_N. Instead of the
actual partners, libraries of oligopeptides,
oligosaccharides, or oligonucleotides
will be necessary. Similarly, solubility
may constitute an issue for some ligand
types, such as lipids. Nonetheless, the
current achievement opens up tremen-
dous possibilities for rational structure-
based de-orphanization. Also, it moves
forward another screening approach
that facilitates solubilization and/or
stabilization of proteins prior to crystalli-
zation (Vedadi et al., 2006). The large
number (2,000) of proteins of solved
structure but unknown function argues
as well for the implementation of automa-
tized approaches. Recent developments
in robotics (le Maire et al., 2011) may
contribute to these efforts, although
design of adequate libraries as well as
automatic data collection and data treat-
ment pipelines will constitute important
milestones to bring X-ray crystallography
into metabolomics.
The work published in this issue of
Structure by Shumilin et al. (2012) repre-
sents an elegant approach to the inter-
twined annotation problem. It provides a
detailed view of enzyme function through
a description of the binding repertoire of
a protein structure at atomic level.
It reconciles structure and function by
identifying reaction products directly in
the active site of a crystallized protein.
This confirms that crystallization is not
providing us with artifactual three-dimen-
sional structures, but instead with active
enzymes. The reappraisal of this crystal
state property opens new avenues for
macromolecular function annotation.ACKNOWLEDGMENTS
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WW domains are small modules that mediate protein/protein interactions. In this issue of Structure, Arago´n
and colleagues show that a WW domain of YAP can mediate complexes with either the canonical PY motif in
an inhibitory Smad or engage in phosphorylation-dependent complexes with one of the activated Smads.
The propensity of YAP WW to recognize a pSP motif is a surprising find with a number of far-reaching
ramifications.Modular protein domains are basic units
of the canonical code of cellular signaling.
The paradigm-changing discovery of
modular protein domains, exemplified by
the characterization of the Src homology
(SH2) domain as a snippet of a protein,
rather than a large surface that is com-
plementary to the cognate ligand pro-
tein (Pawson, 1988), changed our view
of how protein complexes are formed,
regulated, and elicit discrete signals.
In this issue of Structure, Arago´n et al.
(2012) provide an elegant description of
the versatility of one of the smallest
modular protein domains, known as the
WW domain (Bork and Sudol, 1994). By
studying signaling events orchestrated
by transforming growth factor-b and
bone morphogenic protein pathways,
the authors revealed a surprising plas-
ticity of WW domain-containing proteins
in assembling signaling complexes. Two
modes of functional interaction between
Smads and its WW domain-containing
regulators, including a transcriptional co-
activator, YAP, and E3 ubiquitin ligases,such as Nedd4L and Smurf1/2 were
characterized in detail. The authors used
a fine combination of structural biology
to characterize the protein complexes
at high resolution and molecular analyses
in cell culture models to interrogate
the function of the signaling complexes.
One mode of WW domain-mediated
interactions was shown for the inhibitory
Smad (Smad7) as a constitutive and
phosphorylation-independent event. The
first WW domain of YAP isoform,YAP1-2,
was shown to mediate a complex with
the PY motif, also known as PPxY motif,
of Smad7. The other mode of interac-
tion was shown with Smad1, one of the
receptor regulated Smads, as a phos-
phorylation-dependent and composite
complex in which both WW domains of
YAP were involved in unison, recognizing
two sequence motifs within Smad1 (Ara-
go´n et al., 2011). More precisely, in the
interaction with Smad1, the first WW
domain of YAP was engaged in binding
to the phosphorylated serine-proline
motif (serine 206 in human Smad1). Thesecond WW domain of YAP formed a
canonical complex with the adjacent PY
motif of Smad1. The propensity of YAP
WW1 domain to recognize the pSP motif
was a surprising find (Chen and Sudol,
1995). Interestingly, the authors deter-
mined that the affinity of the YAP-WW1-
WW2 for the composite pSP-PY site of
Smad1 was eight times higher than that
of the YAP-WW1 for Smad7, suggesting
a competitive interaction that is balanced
by high local concentrations of Smad7 in
the cell nucleus.
The plasticity of the first WW domain of
YAP in being able to recognize either
canonical PY motif or the phosphorylated
motif, pSP, is appreciated as a novel
finding with important ramifications.
Before the reports of Arago´n and
colleagues, WW domain interactions
with pSP or pTP motifs were limited to
Pin1 WW domain and to a handful of
WW domains of Pin1-related proteins
(Lu et al., 1999). The unique mode of
recognition of phosphorylated motifs by
Pin1 was reinforced by the structure of2012 Elsevier Ltd All rights reserved 1619
